Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Ihab Kamel

Concepts (659)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Neoplasms
125
2025
776
21.680
Why?
Carcinoma, Hepatocellular
75
2025
370
16.550
Why?
Chemoembolization, Therapeutic
43
2024
88
12.060
Why?
Diffusion Magnetic Resonance Imaging
48
2025
158
10.990
Why?
Magnetic Resonance Imaging
141
2025
3926
10.350
Why?
Pancreatic Neoplasms
34
2024
944
5.790
Why?
Cholangiocarcinoma
19
2024
110
5.250
Why?
Contrast Media
61
2025
493
4.800
Why?
Image Enhancement
29
2018
198
4.540
Why?
Tomography, X-Ray Computed
70
2025
2786
4.390
Why?
Image Interpretation, Computer-Assisted
24
2026
295
4.020
Why?
Carcinoma, Pancreatic Ductal
14
2024
297
4.020
Why?
Bile Duct Neoplasms
15
2023
132
3.820
Why?
Liver
41
2026
1864
3.770
Why?
Neuroendocrine Tumors
12
2021
122
3.130
Why?
Liver Cirrhosis
20
2024
278
3.020
Why?
Elasticity Imaging Techniques
9
2023
59
2.780
Why?
Liver Diseases
17
2023
304
2.750
Why?
Pancreatic Cyst
12
2023
50
2.570
Why?
Arrhythmogenic Right Ventricular Dysplasia
16
2022
60
2.430
Why?
Tumor Burden
14
2024
326
2.360
Why?
Retrospective Studies
105
2026
17438
2.350
Why?
Cholangitis, Sclerosing
5
2020
56
2.320
Why?
Middle Aged
180
2026
36619
2.320
Why?
Gadolinium DTPA
20
2025
70
2.290
Why?
Humans
338
2026
146342
2.160
Why?
Algorithms
21
2026
1849
2.100
Why?
Aged
142
2025
26432
2.060
Why?
Cystadenoma, Serous
3
2024
18
1.930
Why?
Pancreatitis
8
2023
146
1.910
Why?
Sensitivity and Specificity
37
2025
1998
1.910
Why?
Male
196
2026
73396
1.790
Why?
Female
207
2026
79499
1.770
Why?
Reproducibility of Results
41
2025
3416
1.740
Why?
Positron-Emission Tomography
10
2023
343
1.710
Why?
Pancreas
13
2024
343
1.680
Why?
Esophageal Neoplasms
13
2025
351
1.650
Why?
Treatment Outcome
60
2025
11821
1.530
Why?
Colorectal Neoplasms
10
2021
874
1.520
Why?
Spleen
4
2020
503
1.520
Why?
Adult
122
2026
41087
1.480
Why?
Carcinoma, Renal Cell
6
2024
231
1.470
Why?
Diagnosis, Differential
27
2025
1503
1.460
Why?
Cholangiopancreatography, Magnetic Resonance
7
2020
24
1.450
Why?
Incidental Findings
5
2024
81
1.450
Why?
Kidney Neoplasms
7
2025
419
1.440
Why?
Splenic Diseases
3
2019
9
1.430
Why?
Iron Overload
4
2024
19
1.370
Why?
Aged, 80 and over
55
2024
8391
1.330
Why?
Adenoma, Liver Cell
4
2024
4
1.330
Why?
Embolization, Therapeutic
11
2022
246
1.320
Why?
Hepatectomy
19
2021
256
1.270
Why?
Liver Transplantation
18
2025
751
1.250
Why?
Diagnostic Imaging
15
2024
340
1.240
Why?
Image Processing, Computer-Assisted
17
2025
778
1.200
Why?
Lymphatic Metastasis
5
2024
335
1.200
Why?
Ultrasonography
8
2026
788
1.200
Why?
Angiomyolipoma
3
2018
21
1.170
Why?
Imaging, Three-Dimensional
16
2025
582
1.160
Why?
Ureteral Obstruction
2
2020
62
1.150
Why?
Biomarkers, Tumor
9
2025
1339
1.140
Why?
Predictive Value of Tests
25
2025
2113
1.120
Why?
Focal Nodular Hyperplasia
5
2018
7
1.110
Why?
Uterine Neoplasms
4
2023
98
1.090
Why?
Magnetic Resonance Angiography
4
2025
249
1.090
Why?
Adipose Tissue
7
2024
642
1.080
Why?
Rectal Neoplasms
6
2024
160
1.080
Why?
Adenoma
4
2024
210
1.080
Why?
Organometallic Compounds
4
2018
110
1.070
Why?
ROC Curve
19
2026
617
1.060
Why?
Prognosis
26
2024
4351
1.050
Why?
Neoadjuvant Therapy
10
2025
475
1.040
Why?
Neoplasm Staging
20
2024
1488
1.030
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1998
1.030
Why?
Kidney Diseases
3
2020
428
1.020
Why?
Bile Ducts, Intrahepatic
13
2023
62
1.010
Why?
Living Donors
6
2021
216
0.970
Why?
Kidney
10
2026
1498
0.970
Why?
Yttrium Radioisotopes
5
2022
64
0.950
Why?
Fibrosis
10
2026
568
0.950
Why?
Survival Rate
19
2024
2092
0.950
Why?
Cardiomyopathy, Hypertrophic
9
2018
144
0.940
Why?
Carcinoma
6
2023
225
0.910
Why?
Leiomyoma
3
2023
62
0.890
Why?
Urinary Bladder Neoplasms
7
2022
259
0.880
Why?
Renal Artery
3
2025
42
0.880
Why?
Pneumonia, Viral
2
2020
387
0.880
Why?
Coronavirus Infections
2
2020
379
0.880
Why?
Nomograms
2
2024
59
0.860
Why?
Societies, Medical
17
2025
907
0.860
Why?
Neoplasm Grading
6
2024
313
0.850
Why?
Magnetic Resonance Spectroscopy
8
2022
627
0.840
Why?
Infusions, Intra-Arterial
6
2019
61
0.800
Why?
Adenomyosis
1
2023
7
0.800
Why?
Uterine Artery Embolization
1
2023
9
0.800
Why?
Gastrointestinal Neoplasms
2
2019
74
0.800
Why?
Prospective Studies
33
2025
8123
0.790
Why?
Gallbladder Neoplasms
1
2023
20
0.790
Why?
Liver Regeneration
6
2017
41
0.790
Why?
Leiomyosarcoma
2
2022
30
0.780
Why?
Doxorubicin
9
2014
416
0.780
Why?
Antineoplastic Agents
10
2019
2219
0.760
Why?
Adenocarcinoma
7
2020
927
0.740
Why?
Neoplasms
7
2021
2954
0.730
Why?
Hemangioma
4
2022
46
0.690
Why?
Positron Emission Tomography Computed Tomography
5
2025
122
0.690
Why?
Evidence-Based Medicine
13
2025
731
0.690
Why?
Immunotherapy
2
2024
671
0.680
Why?
Cholangiopancreatography, Endoscopic Retrograde
3
2019
218
0.670
Why?
Fluorodeoxyglucose F18
3
2022
164
0.660
Why?
Inflammatory Bowel Diseases
2
2023
352
0.660
Why?
Risk Assessment
13
2024
3712
0.660
Why?
Patient Safety
1
2024
352
0.660
Why?
Meglumine
3
2018
18
0.650
Why?
Catheter Ablation
9
2018
355
0.650
Why?
Multidetector Computed Tomography
6
2024
40
0.640
Why?
Lupus Nephritis
3
2026
67
0.630
Why?
Obesity, Abdominal
1
2020
48
0.620
Why?
Adenocarcinoma, Mucinous
3
2018
76
0.620
Why?
Diffusion Tensor Imaging
2
2021
83
0.620
Why?
Subcutaneous Fat
1
2020
80
0.620
Why?
Vascular Diseases
2
2017
252
0.610
Why?
Necrosis
5
2021
243
0.610
Why?
Hepatic Artery
5
2013
53
0.590
Why?
Observer Variation
9
2020
356
0.580
Why?
Young Adult
33
2026
14330
0.580
Why?
Follow-Up Studies
21
2022
5439
0.580
Why?
Radiology
6
2019
175
0.570
Why?
Abdominal Pain
5
2025
149
0.570
Why?
Gastrointestinal Stromal Tumors
1
2019
41
0.560
Why?
Adenoma, Oxyphilic
1
2018
7
0.550
Why?
Biomarkers
10
2026
4340
0.540
Why?
Biliary Tract Diseases
4
2019
32
0.540
Why?
Angiography
5
2013
206
0.540
Why?
Neoplasms, Multiple Primary
1
2018
57
0.530
Why?
Phenylurea Compounds
3
2015
122
0.520
Why?
Niacinamide
3
2015
103
0.520
Why?
Pancreatic Ducts
2
2015
81
0.510
Why?
Fatty Liver
6
2017
252
0.510
Why?
Betacoronavirus
1
2020
288
0.510
Why?
Whole Body Imaging
3
2018
29
0.510
Why?
Tachycardia, Ventricular
5
2022
179
0.510
Why?
Actins
1
2019
422
0.500
Why?
Biopsy
7
2026
1075
0.500
Why?
Magnetic Resonance Imaging, Cine
5
2022
214
0.490
Why?
Defibrillators, Implantable
6
2022
393
0.490
Why?
Lymph Nodes
5
2024
511
0.490
Why?
Response Evaluation Criteria in Solid Tumors
3
2025
21
0.480
Why?
Cystadenoma, Mucinous
1
2016
11
0.480
Why?
Neoplasm Recurrence, Local
8
2023
1160
0.480
Why?
Early Detection of Cancer
9
2024
506
0.470
Why?
Watchful Waiting
1
2016
90
0.460
Why?
Liver Function Tests
4
2025
103
0.460
Why?
Heart Ventricles
8
2018
762
0.460
Why?
Adrenal Gland Neoplasms
1
2016
99
0.450
Why?
Kaplan-Meier Estimate
11
2018
970
0.450
Why?
Radiographic Image Interpretation, Computer-Assisted
3
2025
121
0.430
Why?
Leucovorin
2
2024
98
0.420
Why?
Sarcopenia
6
2016
100
0.420
Why?
Choledochal Cyst
3
2022
16
0.420
Why?
Bile Ducts
3
2019
66
0.420
Why?
Abdomen
2
2013
142
0.410
Why?
Multimodal Imaging
3
2023
137
0.410
Why?
Esophageal and Gastric Varices
2
2024
34
0.410
Why?
United States
33
2026
16136
0.400
Why?
Neoplasm Invasiveness
4
2020
504
0.400
Why?
Fluorouracil
2
2024
231
0.390
Why?
Biliary Tract Neoplasms
1
2013
30
0.390
Why?
Aspartate Aminotransferases
1
2013
86
0.390
Why?
Risk Factors
27
2026
10921
0.390
Why?
Survival Analysis
6
2019
1378
0.390
Why?
Proportional Hazards Models
11
2018
1331
0.380
Why?
Alanine Transaminase
1
2013
151
0.380
Why?
Choline
2
2011
136
0.380
Why?
Organ Size
6
2019
465
0.370
Why?
Phantoms, Imaging
5
2021
160
0.370
Why?
Ventricular Fibrillation
3
2018
63
0.360
Why?
Iron
3
2024
359
0.360
Why?
Ventricular Function, Right
3
2020
300
0.360
Why?
Practice Guidelines as Topic
6
2024
1591
0.350
Why?
Death, Sudden, Cardiac
5
2022
242
0.350
Why?
Models, Biological
2
2016
1761
0.350
Why?
Lupus Erythematosus, Systemic
2
2025
241
0.350
Why?
Authorship
1
2012
51
0.340
Why?
Carcinoma in Situ
3
2021
45
0.340
Why?
Area Under Curve
3
2019
335
0.340
Why?
Liver Neoplasms, Experimental
1
2011
26
0.340
Why?
Myocardial Perfusion Imaging
3
2025
50
0.340
Why?
Ethiodized Oil
3
2021
10
0.340
Why?
Endosonography
5
2020
160
0.330
Why?
Cystadenoma
3
2023
5
0.330
Why?
Arrhythmias, Cardiac
5
2022
358
0.320
Why?
Publishing
1
2012
117
0.320
Why?
Cohort Studies
11
2024
6077
0.320
Why?
Embolism
1
2011
49
0.320
Why?
Echo-Planar Imaging
3
2023
24
0.320
Why?
Radiopharmaceuticals
4
2019
210
0.320
Why?
Tomography, Spiral Computed
4
2007
30
0.320
Why?
Angiomatosis
1
2010
5
0.310
Why?
Non-alcoholic Fatty Liver Disease
4
2021
265
0.310
Why?
SEER Program
3
2024
233
0.310
Why?
Bevacizumab
3
2021
169
0.310
Why?
Radiologists
3
2024
61
0.300
Why?
Breast Neoplasms
6
2021
2418
0.300
Why?
Myocardium
5
2018
948
0.300
Why?
Periodicals as Topic
1
2012
214
0.300
Why?
Disease Progression
7
2019
2867
0.300
Why?
Cystadenocarcinoma
2
2023
4
0.300
Why?
Software
4
2018
676
0.290
Why?
Autoimmune Diseases
1
2013
467
0.290
Why?
Kidney Transplantation
2
2025
735
0.290
Why?
Ventricular Dysfunction, Right
2
2025
248
0.280
Why?
Solitary Fibrous Tumors
1
2008
3
0.280
Why?
Magnetic Resonance Imaging, Interventional
1
2008
30
0.280
Why?
Secretin
3
2019
6
0.280
Why?
Eye Neoplasms
1
2008
31
0.270
Why?
Radiographic Image Enhancement
2
2012
57
0.270
Why?
Artificial Intelligence
3
2022
389
0.270
Why?
Chi-Square Distribution
6
2017
517
0.260
Why?
Adolescent
18
2026
22557
0.260
Why?
Heart Atria
2
2018
139
0.260
Why?
Sentinel Surveillance
2
2018
48
0.260
Why?
Drug Delivery Systems
1
2011
377
0.250
Why?
Rectum
3
2020
180
0.250
Why?
Leiomyomatosis
1
2007
4
0.250
Why?
Hepatic Veins
3
2003
28
0.250
Why?
Neovascularization, Pathologic
2
2008
287
0.250
Why?
Myocardial Contraction
2
2018
292
0.240
Why?
Psoas Muscles
3
2015
24
0.240
Why?
Pancreatectomy
5
2020
289
0.240
Why?
RNA, Small Cytoplasmic
1
2026
7
0.240
Why?
Antibodies, Antinuclear
1
2026
60
0.240
Why?
Ventricular Outflow Obstruction
2
2016
38
0.230
Why?
Kidney Tubules
1
2026
117
0.220
Why?
Models, Statistical
3
2019
669
0.220
Why?
Liver Failure
2
2016
79
0.220
Why?
Ribonucleoproteins
1
2026
106
0.220
Why?
Amyloidosis
1
2025
43
0.210
Why?
Proteinuria
1
2025
103
0.210
Why?
Portal Vein
6
2012
123
0.210
Why?
Disease Models, Animal
4
2020
4580
0.210
Why?
Collateral Circulation
1
2004
20
0.210
Why?
Cardiomyopathies
2
2025
340
0.210
Why?
Scleroderma, Systemic
1
2025
124
0.200
Why?
Computed Tomography Angiography
1
2025
151
0.200
Why?
Pancreas, Exocrine
1
2024
7
0.200
Why?
Rats, Sprague-Dawley
2
2020
2537
0.200
Why?
Protons
4
2020
96
0.200
Why?
Hypertension, Portal
1
2004
66
0.200
Why?
Safety Management
1
2024
130
0.200
Why?
Carcinoma, Papillary
2
2014
83
0.200
Why?
Atrophy
3
2026
199
0.190
Why?
Feasibility Studies
7
2024
1135
0.190
Why?
Cholecystitis, Acute
1
2023
26
0.190
Why?
Colitis, Ulcerative
1
2024
143
0.190
Why?
Pulmonary Embolism
1
2025
246
0.190
Why?
Gastrointestinal Hemorrhage
1
2024
134
0.190
Why?
Severity of Illness Index
5
2026
2921
0.190
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2023
62
0.180
Why?
alpha-Fetoproteins
2
2013
42
0.180
Why?
Pancreatitis, Chronic
2
2020
64
0.180
Why?
Electrocardiography
4
2020
667
0.180
Why?
Hemangioma, Cavernous
1
2022
11
0.180
Why?
Kasabach-Merritt Syndrome
1
2022
8
0.180
Why?
Cysts
1
2023
108
0.180
Why?
Time Factors
11
2018
7109
0.180
Why?
Decision Support Systems, Clinical
1
2026
279
0.180
Why?
Statistics, Nonparametric
5
2019
426
0.180
Why?
Atrial Fibrillation
2
2018
560
0.180
Why?
Graft Rejection
1
2025
516
0.180
Why?
Hemodynamics
2
2025
1114
0.170
Why?
Ultrasonography, Mammary
1
2021
17
0.170
Why?
Pandemics
2
2020
1707
0.170
Why?
Melanoma
1
2008
765
0.170
Why?
Single-Blind Method
2
2017
313
0.170
Why?
Nuclear Medicine
1
2021
9
0.170
Why?
Rats
2
2020
5586
0.160
Why?
National Institutes of Health (U.S.)
1
2022
147
0.160
Why?
Biomedical Research
2
2022
729
0.160
Why?
Crohn Disease
1
2024
250
0.160
Why?
Semaphorins
1
2021
37
0.160
Why?
Cholestasis
1
2023
217
0.160
Why?
Awards and Prizes
1
2022
72
0.160
Why?
Reference Values
2
2020
796
0.160
Why?
Gadolinium
4
2021
78
0.160
Why?
Rabbits
3
2011
651
0.160
Why?
Margins of Excision
1
2020
55
0.160
Why?
Regression Analysis
3
2018
999
0.160
Why?
Italy
1
2020
118
0.160
Why?
Maryland
3
2016
67
0.160
Why?
Kidney Cortex
1
2020
27
0.160
Why?
Cancer Care Facilities
1
2021
48
0.160
Why?
Kidney Medulla
1
2020
28
0.160
Why?
Thorax
1
2020
51
0.160
Why?
Ferric Compounds
2
2012
55
0.150
Why?
Esophageal Mucosa
1
2020
22
0.150
Why?
Inflammation
1
2011
2919
0.150
Why?
Ursodeoxycholic Acid
1
2019
16
0.150
Why?
Digestive System Neoplasms
1
2019
9
0.150
Why?
Ultrasonography, Doppler, Color
1
2019
37
0.150
Why?
Mammography
1
2021
175
0.150
Why?
Combined Modality Therapy
6
2016
1271
0.150
Why?
Cardiac-Gated Imaging Techniques
2
2016
21
0.150
Why?
Drug Therapy, Combination
3
2024
1036
0.150
Why?
Recurrence
2
2020
1133
0.150
Why?
Jaundice
1
2019
10
0.150
Why?
Mutation
4
2015
4093
0.150
Why?
Prevalence
5
2023
2861
0.150
Why?
Radiography
6
2022
861
0.150
Why?
Ovarian Neoplasms
1
2025
604
0.140
Why?
Elasticity
1
2019
187
0.140
Why?
Microspheres
5
2016
142
0.140
Why?
Epidemiologic Methods
1
2019
91
0.140
Why?
Jejunum
1
2019
36
0.140
Why?
Vaccines
1
2024
389
0.140
Why?
Chronic Disease
4
2017
1827
0.140
Why?
Appendicitis
1
2000
151
0.140
Why?
Pyridines
3
2021
610
0.140
Why?
Mucins
1
2019
75
0.140
Why?
Cardiac Imaging Techniques
2
2018
24
0.140
Why?
Postoperative Complications
4
2016
3034
0.140
Why?
Gastrointestinal Agents
1
2019
63
0.140
Why?
Artifacts
2
2016
143
0.140
Why?
Viscera
1
2018
17
0.140
Why?
Brachytherapy
1
2019
132
0.140
Why?
Pericardium
1
2018
59
0.130
Why?
Logistic Models
4
2026
2126
0.130
Why?
Equipment Safety
1
2017
38
0.130
Why?
Caloric Restriction
1
2019
133
0.130
Why?
Hemochromatosis
1
2017
9
0.130
Why?
Animals
10
2020
38107
0.130
Why?
Disease Susceptibility
1
2019
339
0.130
Why?
Ventricular Flutter
1
2017
2
0.130
Why?
Sepsis
1
2024
669
0.130
Why?
Tomography, Emission-Computed
2
2010
71
0.130
Why?
Metastasectomy
1
2017
19
0.130
Why?
Adrenocortical Adenoma
1
2016
2
0.120
Why?
Lymphography
1
2016
13
0.120
Why?
Breath Holding
1
2016
10
0.120
Why?
Pulmonary Veins
1
2018
110
0.120
Why?
Referral and Consultation
2
2013
881
0.120
Why?
Lung
2
2020
4122
0.120
Why?
Radiotherapy
2
2008
209
0.120
Why?
Incidence
6
2020
2936
0.120
Why?
Obesity
3
2023
3131
0.120
Why?
Electric Countershock
1
2017
126
0.120
Why?
Motion
1
2016
94
0.120
Why?
Pacemaker, Artificial
1
2017
127
0.120
Why?
Evaluation Studies as Topic
1
2016
161
0.120
Why?
Neoplasms, Second Primary
1
2017
103
0.120
Why?
Disease Management
3
2015
651
0.120
Why?
Body Water
1
2016
23
0.120
Why?
Pancreatic Juice
2
2012
3
0.120
Why?
Benzamides
1
2017
226
0.120
Why?
Coronary Circulation
2
2015
134
0.120
Why?
Carcinoid Tumor
2
2008
21
0.120
Why?
Platelet Count
1
2016
95
0.120
Why?
Primary Prevention
1
2018
222
0.120
Why?
Multivariate Analysis
6
2017
1543
0.120
Why?
Azacitidine
1
2017
168
0.120
Why?
Phosphorus
1
2016
89
0.110
Why?
Echocardiography
2
2016
645
0.110
Why?
Adrenal Cortex Neoplasms
1
2016
70
0.110
Why?
Adiposity
1
2020
533
0.110
Why?
Pancreatitis, Acute Necrotizing
1
2015
14
0.110
Why?
Bariatric Surgery
1
2019
250
0.110
Why?
Hepatopulmonary Syndrome
1
2015
23
0.110
Why?
Fractures, Spontaneous
2
2005
15
0.110
Why?
Telomere Homeostasis
1
2015
35
0.110
Why?
Carcinoma, Squamous Cell
1
2020
628
0.110
Why?
Bone Neoplasms
1
2018
272
0.110
Why?
Body Composition
1
2019
689
0.110
Why?
Hospital Costs
1
2016
131
0.110
Why?
Hypertrophy, Left Ventricular
1
2016
124
0.110
Why?
Digestive System Surgical Procedures
1
2016
115
0.110
Why?
Insulin
1
2026
2525
0.110
Why?
Fractures, Stress
2
2005
32
0.110
Why?
Telomere
2
2015
300
0.110
Why?
Patient Care Team
1
2021
701
0.110
Why?
Preoperative Care
3
2024
396
0.110
Why?
Frail Elderly
1
2015
141
0.110
Why?
Image-Guided Biopsy
1
2014
41
0.110
Why?
Biliary Tract
2
2012
13
0.110
Why?
Acrylic Resins
2
2012
48
0.100
Why?
Disease-Free Survival
4
2022
778
0.100
Why?
Gene Expression
1
2019
1463
0.100
Why?
Gelatin
2
2012
56
0.100
Why?
Receptors, Vascular Endothelial Growth Factor
1
2014
109
0.100
Why?
Abdomen, Acute
1
2014
20
0.100
Why?
Antibiotics, Antineoplastic
2
2012
141
0.100
Why?
Fissure in Ano
1
2013
4
0.100
Why?
Cholecystitis
1
2014
25
0.100
Why?
Critical Illness
1
2020
908
0.100
Why?
Receptor, Angiotensin, Type 1
1
2013
25
0.100
Why?
Linear Models
3
2011
857
0.100
Why?
Decision Support Techniques
1
2018
478
0.100
Why?
Delayed-Action Preparations
1
2014
192
0.100
Why?
Genetic Predisposition to Disease
5
2013
2488
0.100
Why?
Dyspnea
1
2015
251
0.100
Why?
Ventricular Remodeling
1
2016
283
0.100
Why?
Hypertension, Pulmonary
1
2025
1957
0.100
Why?
Rectal Fistula
1
2013
26
0.100
Why?
Analysis of Variance
2
2013
1298
0.100
Why?
Carcinoma, Transitional Cell
2
2005
70
0.100
Why?
Pattern Recognition, Automated
1
2013
74
0.100
Why?
Weight Loss
1
2019
858
0.100
Why?
Tetrazoles
1
2013
50
0.100
Why?
Pelvic Neoplasms
1
2013
24
0.100
Why?
Cystic Fibrosis
1
2023
1164
0.100
Why?
Postoperative Period
3
2016
355
0.100
Why?
Abdominal Neoplasms
1
2013
48
0.090
Why?
Protein Phosphatase 1
1
2013
32
0.090
Why?
Liver Circulation
1
2012
12
0.090
Why?
Iohexol
1
2012
23
0.090
Why?
Endoscopy, Digestive System
2
2024
141
0.090
Why?
Academic Medical Centers
2
2013
561
0.090
Why?
GTP-Binding Protein alpha Subunits, Gs
1
2012
9
0.090
Why?
Acute Disease
3
2023
1038
0.090
Why?
Polyvinyls
1
2012
19
0.090
Why?
Lipase
1
2013
76
0.090
Why?
Prednisone
1
2013
229
0.090
Why?
Ventricular Function, Left
1
2016
541
0.090
Why?
Vascular Neoplasms
1
2012
19
0.090
Why?
Imidazoles
1
2013
245
0.090
Why?
Computer Simulation
1
2016
1014
0.090
Why?
Electrophysiologic Techniques, Cardiac
3
2018
82
0.090
Why?
Peer Review, Research
1
2012
36
0.090
Why?
Glucocorticoids
2
2013
536
0.090
Why?
DNA Methylation
1
2017
725
0.090
Why?
Bibliometrics
1
2012
68
0.090
Why?
Neoplastic Cells, Circulating
1
2012
81
0.090
Why?
Editorial Policies
1
2012
46
0.090
Why?
World Health Organization
2
2022
104
0.090
Why?
Intra-Abdominal Fat
2
2024
104
0.080
Why?
Precancerous Conditions
1
2012
162
0.080
Why?
Myocardial Ischemia
1
2013
286
0.080
Why?
Angiogenesis Inhibitors
1
2012
239
0.080
Why?
Cell Transformation, Neoplastic
2
2024
314
0.080
Why?
Respiration
2
2017
208
0.080
Why?
Coronary Vessels
1
2012
245
0.080
Why?
Practice Patterns, Physicians'
3
2021
1408
0.080
Why?
Chemotherapy, Adjuvant
2
2024
429
0.080
Why?
Sclerosis
1
2010
11
0.080
Why?
Urinary Bladder
2
2022
194
0.080
Why?
Guidelines as Topic
1
2012
267
0.080
Why?
Regional Blood Flow
1
2012
507
0.080
Why?
Polymorphism, Genetic
1
2013
612
0.080
Why?
Dose-Response Relationship, Drug
1
2014
2022
0.080
Why?
Adaptor Proteins, Signal Transducing
1
2013
429
0.080
Why?
Splenectomy
1
2010
61
0.080
Why?
Pituitary-Adrenal System
1
2011
169
0.080
Why?
Cell Proliferation
1
2017
2502
0.070
Why?
Hypothalamo-Hypophyseal System
1
2011
204
0.070
Why?
Glomerular Filtration Rate
2
2025
745
0.070
Why?
Saliva
1
2011
256
0.070
Why?
Immunoglobulin G
1
2013
901
0.070
Why?
Ultrasonic Therapy
1
2009
16
0.070
Why?
Hydrocortisone
1
2011
303
0.070
Why?
Tumor Suppressor Protein p53
1
2012
530
0.070
Why?
Pilot Projects
3
2019
1888
0.070
Why?
Heart
3
2017
626
0.070
Why?
Stroke Volume
2
2022
652
0.070
Why?
Baltimore
3
2015
71
0.070
Why?
Exercise
2
2019
2213
0.070
Why?
Organoplatinum Compounds
2
2019
65
0.070
Why?
Carcinoma, Islet Cell
1
2008
1
0.070
Why?
Brain
1
2020
2991
0.070
Why?
Lipids
1
2013
714
0.070
Why?
Internet
1
2012
660
0.060
Why?
Intestinal Neoplasms
2
2004
31
0.060
Why?
Catheterization, Peripheral
1
2008
116
0.060
Why?
Soft Tissue Neoplasms
1
2008
133
0.060
Why?
Membrane Proteins
1
2013
1130
0.060
Why?
Circadian Rhythm
1
2011
515
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2012
992
0.060
Why?
Duodenum
2
2019
76
0.060
Why?
Pyridoxal Phosphate
1
2005
20
0.060
Why?
Uterus
1
2007
227
0.060
Why?
Gallbladder Diseases
1
2005
12
0.060
Why?
Edetic Acid
1
2005
47
0.060
Why?
Cross-Sectional Studies
4
2022
5899
0.060
Why?
Minimally Invasive Surgical Procedures
1
2007
196
0.060
Why?
Sus scrofa
2
2016
64
0.050
Why?
Ultrasonography, Doppler
1
2025
122
0.050
Why?
Iodized Oil
3
2012
3
0.050
Why?
Case-Control Studies
3
2019
3647
0.050
Why?
Portography
1
2004
7
0.050
Why?
Splenic Vein
1
2004
2
0.050
Why?
Portal System
1
2004
12
0.050
Why?
Mesenteric Vascular Occlusion
1
2004
5
0.050
Why?
Myometrium
1
2005
38
0.050
Why?
Esophagectomy
1
2025
136
0.050
Why?
Receptors, Somatostatin
1
2004
24
0.050
Why?
Somatostatin
1
2004
54
0.050
Why?
Age Factors
3
2018
3347
0.050
Why?
Mesenteric Veins
1
2004
28
0.050
Why?
Arteriosclerosis
1
2004
82
0.050
Why?
Calibration
1
2024
154
0.050
Why?
Peripheral Vascular Diseases
1
2004
102
0.050
Why?
Ovary
1
2025
236
0.050
Why?
Body Mass Index
3
2019
2458
0.050
Why?
Constriction, Pathologic
1
2004
240
0.050
Why?
Carcinosarcoma
1
2003
23
0.050
Why?
Mycophenolic Acid
1
2024
117
0.050
Why?
Ipilimumab
1
2023
44
0.050
Why?
Pelvis
1
2024
129
0.050
Why?
Creatinine
1
2025
511
0.050
Why?
Common Bile Duct
1
2022
14
0.050
Why?
Intestine, Small
1
2004
160
0.050
Why?
Ventricular Dysfunction, Left
1
2006
391
0.050
Why?
Heart Aneurysm
1
2002
11
0.050
Why?
Child
5
2026
22693
0.050
Why?
X-Rays
1
2022
27
0.040
Why?
Kinetics
2
2017
1553
0.040
Why?
Registries
3
2018
2400
0.040
Why?
Financing, Organized
1
2022
36
0.040
Why?
Heart Failure
1
2015
2329
0.040
Why?
Hormones
1
2022
134
0.040
Why?
Financing, Government
1
2022
53
0.040
Why?
Research Support as Topic
1
2022
83
0.040
Why?
Morbidity
2
2013
319
0.040
Why?
Aorta, Thoracic
1
2004
284
0.040
Why?
Anilides
1
2021
83
0.040
Why?
Pedigree
2
2012
512
0.040
Why?
B7-H1 Antigen
1
2023
245
0.040
Why?
Fluoroscopy
1
2021
179
0.040
Why?
Cholinergic Agents
1
2020
18
0.040
Why?
Patient Selection
2
2017
728
0.040
Why?
Breast
1
2021
155
0.040
Why?
Mitomycin
2
2012
31
0.040
Why?
Monitoring, Physiologic
1
2002
279
0.040
Why?
Preoperative Period
1
2020
157
0.040
Why?
Length of Stay
2
2016
1358
0.040
Why?
Appendectomy
1
2000
93
0.040
Why?
Aorta
1
2023
440
0.040
Why?
Islets of Langerhans Transplantation
1
2020
72
0.040
Why?
Hepatitis C
1
2002
251
0.040
Why?
Precision Medicine
1
2024
462
0.040
Why?
Cachexia
1
2020
74
0.040
Why?
Gastroplasty
1
2019
31
0.040
Why?
Emergencies
1
2000
177
0.040
Why?
Surveys and Questionnaires
1
2012
6073
0.040
Why?
Data Accuracy
1
2019
64
0.040
Why?
Pancreatic Function Tests
1
2019
4
0.040
Why?
Immunosuppressive Agents
1
2024
829
0.040
Why?
Longitudinal Studies
2
2018
3017
0.030
Why?
Absorptiometry, Photon
1
2019
278
0.030
Why?
Risk
1
2021
920
0.030
Why?
Cisplatin
2
2012
347
0.030
Why?
Gastric Bypass
1
2019
115
0.030
Why?
Paclitaxel
1
2019
260
0.030
Why?
Insulin Resistance
1
2026
1247
0.030
Why?
Electric Power Supplies
1
2017
46
0.030
Why?
Neoplasm Metastasis
2
2012
693
0.030
Why?
Global Health
1
2020
403
0.030
Why?
Equipment Failure
1
2017
112
0.030
Why?
HCT116 Cells
1
2017
78
0.030
Why?
Infant
3
2022
10114
0.030
Why?
Zinc Finger Protein Gli3
1
2016
3
0.030
Why?
Camptothecin
1
2017
139
0.030
Why?
Xenopus Proteins
1
2016
33
0.030
Why?
Electrocardiography, Ambulatory
1
2017
64
0.030
Why?
Pain
1
2022
790
0.030
Why?
Radionuclide Imaging
2
2008
116
0.030
Why?
Hemorrhage
1
2022
825
0.030
Why?
Databases, Factual
2
2016
1493
0.030
Why?
Consensus
1
2018
467
0.030
Why?
Equipment Failure Analysis
1
2016
124
0.030
Why?
Phenotype
2
2015
3206
0.030
Why?
Exudates and Transudates
1
2015
12
0.030
Why?
Machine Learning
1
2021
594
0.030
Why?
Advisory Committees
1
2017
228
0.030
Why?
Intensive Care Units
1
2022
925
0.030
Why?
Species Specificity
1
2016
543
0.030
Why?
Cell Line, Tumor
2
2017
3545
0.030
Why?
Echocardiography, Stress
1
2015
29
0.030
Why?
Drug Administration Schedule
1
2017
790
0.030
Why?
Models, Animal
1
2016
387
0.030
Why?
Heterozygote
1
2015
311
0.030
Why?
Delivery of Health Care
1
2021
947
0.030
Why?
Sex Factors
2
2015
2107
0.030
Why?
Equipment Design
1
2016
520
0.030
Why?
Compressive Strength
1
2014
72
0.030
Why?
Biomechanical Phenomena
1
2017
874
0.020
Why?
Autoradiography
1
2013
65
0.020
Why?
Injections, Intra-Arterial
1
2013
25
0.020
Why?
Geriatric Assessment
1
2015
244
0.020
Why?
Clinical Decision-Making
1
2017
365
0.020
Why?
Blood Cell Count
1
2013
56
0.020
Why?
Anaplasia
1
2013
7
0.020
Why?
Netherlands
1
2013
85
0.020
Why?
Epithelial Cells
1
2020
1119
0.020
Why?
Research Design
2
2011
1143
0.020
Why?
Fractional Flow Reserve, Myocardial
1
2013
10
0.020
Why?
Phospholipases A2, Calcium-Independent
1
2013
18
0.020
Why?
Pressure
1
2014
221
0.020
Why?
Telomerase
1
2015
252
0.020
Why?
Molecular Imaging
1
2013
58
0.020
Why?
Cicatrix
1
2013
72
0.020
Why?
Chromogranins
1
2012
13
0.020
Why?
Acyltransferases
1
2013
78
0.020
Why?
Radiology, Interventional
1
2013
49
0.020
Why?
Chemoradiotherapy, Adjuvant
1
2012
44
0.020
Why?
Mutant Proteins
1
2012
103
0.020
Why?
Microcirculation
1
2013
142
0.020
Why?
Heredity
1
2012
13
0.020
Why?
Epigenesis, Genetic
1
2017
712
0.020
Why?
In Situ Hybridization, Fluorescence
1
2013
334
0.020
Why?
DNA, Neoplasm
1
2012
160
0.020
Why?
Choice Behavior
1
2013
179
0.020
Why?
Mexican Americans
1
2013
119
0.020
Why?
Bilirubin
1
2012
101
0.020
Why?
Sampling Studies
1
2011
97
0.020
Why?
Benzenesulfonates
1
2011
23
0.020
Why?
Gene Frequency
1
2013
496
0.020
Why?
China
1
2012
280
0.020
Why?
Hepatitis B, Chronic
1
2011
22
0.020
Why?
Nutrition Surveys
1
2013
270
0.020
Why?
Treatment Failure
1
2012
361
0.020
Why?
Ligands
1
2013
678
0.020
Why?
Asymptomatic Diseases
1
2012
102
0.020
Why?
Early Diagnosis
1
2012
251
0.020
Why?
Allostasis
1
2011
17
0.020
Why?
Europe
1
2012
421
0.020
Why?
Antibiotic Prophylaxis
1
2012
140
0.020
Why?
Genetic Association Studies
1
2013
379
0.020
Why?
Vasodilator Agents
1
2013
326
0.020
Why?
Confidence Intervals
1
2011
329
0.020
Why?
Adrenal Glands
1
2011
77
0.020
Why?
Canada
1
2012
432
0.020
Why?
Gastroenterology
1
2013
187
0.020
Why?
General Surgery
1
2013
217
0.020
Why?
Medical Oncology
1
2013
345
0.020
Why?
Action Potentials
1
2013
500
0.020
Why?
Hepatitis C, Chronic
1
2011
150
0.020
Why?
Molecular Targeted Therapy
1
2012
447
0.020
Why?
Sodium Isotopes
1
2009
2
0.020
Why?
Neoplasm Proteins
1
2012
444
0.020
Why?
Immunohistochemistry
1
2013
1712
0.020
Why?
Dexamethasone
1
2011
368
0.020
Why?
Thrombosis
1
2012
398
0.020
Why?
Tissue Distribution
1
2008
334
0.020
Why?
Bile Ducts, Extrahepatic
1
2006
19
0.020
Why?
Healthcare Disparities
1
2013
733
0.010
Why?
Femoral Artery
1
2007
183
0.010
Why?
Mass Screening
1
2014
1307
0.010
Why?
Blood Glucose
1
2016
2360
0.010
Why?
Gallbladder
1
2005
15
0.010
Why?
Child, Preschool
2
2014
11913
0.010
Why?
Tissue Survival
1
2005
17
0.010
Why?
Diabetes Mellitus, Type 2
1
2019
2623
0.010
Why?
Adenoma, Islet Cell
1
2004
6
0.010
Why?
Indium Radioisotopes
1
2004
12
0.010
Why?
Bone Diseases
1
2005
60
0.010
Why?
Radiography, Interventional
1
2005
128
0.010
Why?
Mice
1
2020
18297
0.010
Why?
Aneurysm, False
1
2002
46
0.010
Why?
Palliative Care
1
2005
1032
0.010
Why?
Myocardial Infarction
1
2002
1215
0.010
Why?
Kamel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)